COVID-19 Advanced Respiratory Physiology (CARP) Study
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Biosensor
- COVID-19
- Respiratory Failure
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
Altair medical has developed a pre-commercial investigational wearable (chest-worn) biosensor which can measure continuous respiratory rate and respiratory events. This sensor has been verified to have good correlation with reference impedance plethysmography data. Inclusion criteria: All inpatients...
Altair medical has developed a pre-commercial investigational wearable (chest-worn) biosensor which can measure continuous respiratory rate and respiratory events. This sensor has been verified to have good correlation with reference impedance plethysmography data. Inclusion criteria: All inpatients in the QEUH with respiratory failure from any cause. Exclusion criteria: Lack of capacity to consent Physiology data will be correlated with event time-course data including oxygen and breathing support requirements, deterioration, hospital discharge and status at 28 days and 90 days post discharge. A small subset of patients will have further investigations - parasternal EMG; thoracic electrical impedance tomography; forced oscillometry and post discharge Altair and Fitbit data. Study analysis will include machine learning model development with the objective of developing risk-predictions for clinically significant deteriorations.
Tracking Information
- NCT #
- NCT04668313
- Collaborators
- Altair Medical
- Storm ID
- Investigators
- Not Provided